ArticleNPJ precision oncology2024

HuR inhibition overcomes cFLIP-mediated doxorubicin resistance in triple-negative breast cancer.

Lanjing Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.